FR2918570B1 - DIGLYCATION DES AGEs. - Google Patents

DIGLYCATION DES AGEs.

Info

Publication number
FR2918570B1
FR2918570B1 FR0756350A FR0756350A FR2918570B1 FR 2918570 B1 FR2918570 B1 FR 2918570B1 FR 0756350 A FR0756350 A FR 0756350A FR 0756350 A FR0756350 A FR 0756350A FR 2918570 B1 FR2918570 B1 FR 2918570B1
Authority
FR
France
Prior art keywords
diglycation
ages
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0756350A
Other languages
English (en)
Other versions
FR2918570A1 (fr
Inventor
Malak Nabil Abdul
Cecile Altobelli
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Engelhard Lyon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0756350A priority Critical patent/FR2918570B1/fr
Application filed by Engelhard Lyon SA filed Critical Engelhard Lyon SA
Priority to KR1020107002758A priority patent/KR20100047253A/ko
Priority to CN201410105347.2A priority patent/CN103816095A/zh
Priority to EP08786013A priority patent/EP2170358A2/fr
Priority to BRPI0813925-3A2A priority patent/BRPI0813925A2/pt
Priority to PCT/EP2008/058955 priority patent/WO2009007412A2/fr
Priority to JP2010515508A priority patent/JP2010533143A/ja
Priority to US12/668,061 priority patent/US20100203175A1/en
Priority to CN200880101123A priority patent/CN101765432A/zh
Publication of FR2918570A1 publication Critical patent/FR2918570A1/fr
Priority to FR1257027A priority patent/FR2975495B1/fr
Application granted granted Critical
Publication of FR2918570B1 publication Critical patent/FR2918570B1/fr
Priority to JP2013169506A priority patent/JP2014028814A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
FR0756350A 2007-07-09 2007-07-09 DIGLYCATION DES AGEs. Active FR2918570B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0756350A FR2918570B1 (fr) 2007-07-09 2007-07-09 DIGLYCATION DES AGEs.
CN200880101123A CN101765432A (zh) 2007-07-09 2008-07-09 Age的去糖化
EP08786013A EP2170358A2 (fr) 2007-07-09 2008-07-09 Deglycation des ages.
BRPI0813925-3A2A BRPI0813925A2 (pt) 2007-07-09 2008-07-09 Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição.
PCT/EP2008/058955 WO2009007412A2 (fr) 2007-07-09 2008-07-09 Deglycation des ages
JP2010515508A JP2010533143A (ja) 2007-07-09 2008-07-09 Ａｇｅの脱糖化
KR1020107002758A KR20100047253A (ko) 2007-07-09 2008-07-09 Ａｇｅ 탈당화
CN201410105347.2A CN103816095A (zh) 2007-07-09 2008-07-09 高级糖化终产物的去糖化
US12/668,061 US20100203175A1 (en) 2007-07-09 2008-07-09 DEGLYCATION OF AGEs
FR1257027A FR2975495B1 (fr) 2007-07-09 2012-07-20 Methode de criblage de principes actifs favorisant la deglycation des ages
JP2013169506A JP2014028814A (ja) 2007-07-09 2013-08-19 Ａｇｅの脱糖化

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0756350A FR2918570B1 (fr) 2007-07-09 2007-07-09 DIGLYCATION DES AGEs.

Publications (2)

Publication Number Publication Date
FR2918570A1 FR2918570A1 (fr) 2009-01-16
FR2918570B1 true FR2918570B1 (fr) 2012-10-05

Family

ID=39262794

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0756350A Active FR2918570B1 (fr) 2007-07-09 2007-07-09 DIGLYCATION DES AGEs.
FR1257027A Active FR2975495B1 (fr) 2007-07-09 2012-07-20 Methode de criblage de principes actifs favorisant la deglycation des ages

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR1257027A Active FR2975495B1 (fr) 2007-07-09 2012-07-20 Methode de criblage de principes actifs favorisant la deglycation des ages

Country Status (8)

Country Link
US (1) US20100203175A1 (fr)
EP (1) EP2170358A2 (fr)
JP (2) JP2010533143A (fr)
KR (1) KR20100047253A (fr)
CN (2) CN103816095A (fr)
BR (1) BRPI0813925A2 (fr)
FR (2) FR2918570B1 (fr)
WO (1) WO2009007412A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928548B1 (fr) * 2008-03-14 2015-07-03 Basf Beauty Care Solutions F Substances augmentant le seuil d'activation des cellules immunes
JP2010077123A (ja) * 2008-08-29 2010-04-08 Hayashikane Sangyo Kk メイラード反応阻害剤
FR2951085B1 (fr) * 2009-10-09 2012-05-18 Inst Substances Vegetales Utilisation de composes phenoliques pour la deglycation des proteines
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
JP5878023B2 (ja) * 2010-02-10 2016-03-08 オリザ油化株式会社 Ａｇｅ産生抑制剤
JP6012138B2 (ja) * 2010-10-04 2016-10-25 小林製薬株式会社 抗糖化剤
JP5855492B2 (ja) * 2012-02-27 2016-02-09 三省製薬株式会社 ＡＧＥｓ産生抑制剤
JP6054700B2 (ja) * 2012-10-10 2016-12-27 株式会社ノエビア 脱糖化剤及び皮膚外用剤
JP2015096488A (ja) * 2013-10-10 2015-05-21 康二 嘉島 終末糖化物質生成抑制方法
CN105770357A (zh) * 2015-10-16 2016-07-20 北京冠瑞金生物科技有限公司 蒜氨酸在制备抗抑郁症药物中的用途
JP2017088538A (ja) * 2015-11-10 2017-05-25 日本メナード化粧品株式会社 フィラグリン産生促進剤
KR102605628B1 (ko) * 2015-12-29 2023-11-22 주식회사 엘지생활건강 하스타토사이드를 포함하는 피부상태 개선용 조성물
EP3641725A1 (fr) * 2017-06-23 2020-04-29 The Procter and Gamble Company Composition et procédé permettant d'améliorer l'aspect de la peau
JP2019214546A (ja) * 2018-06-11 2019-12-19 学校法人福岡大学 終末糖化産物生成抑制剤及び医薬組成物
CA3102288A1 (fr) 2018-07-03 2020-01-09 The Procter & Gamble Company Methode de traitement d'une affection cutanee
CN109468370A (zh) * 2018-11-09 2019-03-15 广州益养生物科技有限公司 一种快速检测遗传性皮肤糖基化能力基因的方法
CN110684212A (zh) * 2019-10-31 2020-01-14 东南大学 一种仿贻贝的水下高粘性水凝胶的制备方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (fr) 2020-06-01 2023-04-05 The Procter & Gamble Company Méthode d'amélioration de la pénétration d'un composé de vitamine b3 dans la peau
CN112111020B (zh) * 2020-10-26 2022-07-19 无锡善元健康管理有限公司 桦树茸中抗糖成分的提取纯化及抗糖丸的制备方法
CN112370370B (zh) * 2020-11-19 2022-07-26 苏州禾研生物技术有限公司 一种氧糖双抗的组合物及其应用和氧糖双抗的产品
CN113876668B (zh) * 2021-11-16 2023-11-03 上海青颜博识生物技术有限公司 一种抗糖化植物来源组合物及其制备方法和在美容产品中的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847267A (en) * 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method
JP2552297B2 (ja) * 1987-07-03 1996-11-06 ポーラ化成工業株式会社 美肌化粧料
FR2653336B1 (fr) * 1989-10-20 1994-04-08 Oreal Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
EP0958810B1 (fr) * 1991-11-25 2003-05-02 Richardson-Vicks Inc. Utilisation de l'acide salicylique dans le traitement des rides de la peau et/ou contre l'atrophie cutanée
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
JP3625501B2 (ja) * 1994-10-06 2005-03-02 御木本製薬株式会社 細胞賦活用皮膚外用剤原料の製造方法及び細胞賦活用皮膚外用剤
JPH08133940A (ja) * 1994-11-02 1996-05-28 Pola Chem Ind Inc 紫外線吸収剤及びこれを含有する化粧料
JPH0977655A (ja) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
FR2764190B1 (fr) * 1997-06-06 1999-10-15 Serobiologiques Lab Sa Produit cosmetique comprenant des extraits de plantes notamment a action depigmentante, antiradicalaire et anti-vieillissement
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
FR2787324B1 (fr) * 1998-12-21 2001-02-23 Serobiologiques Lab Sa Utilisation d'au moins un extrait d'une plante appartenant au genre cecropia et composition cosmetique ou dermopharmaceutique comportant un tel extrait
JP2000256259A (ja) * 1999-03-11 2000-09-19 Nippon Zoki Pharmaceut Co Ltd メイラード反応阻害剤
US6589944B1 (en) * 1999-04-05 2003-07-08 City Of Hope Breakers of advanced glycation endproducts
CA2368688C (fr) * 1999-04-05 2009-08-11 City Of Hope Nouveaux inhibiteurs de la formation de produits terminaux de glycosylation avancee (age)
US6787566B2 (en) * 1999-04-05 2004-09-07 City Of Hope Breakers of advanced glycation endproducts
EP1145709A1 (fr) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Utilisation de produits naturels pour préparer des compositions cosmétiques
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
PT1373263E (pt) * 2001-04-05 2005-03-31 Torrent Pharmaceuticals Ltd Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas
EP1435930A2 (fr) * 2001-10-15 2004-07-14 National Research Council Of Canada Agents anti-glycation destines a la prevention des complications liees a l'age, au diabete et au tabagisme
HUP0104832A2 (en) * 2001-10-19 2003-08-28 Torrent Pharmaceuticals Ltd Cosmetic composition and method
KR20040038243A (ko) * 2002-10-31 2004-05-08 (주)마이코스메틱 생열귀나무 추출물을 함유하는 항산화 또는 항노화용 피부화장료 조성물
JP4247091B2 (ja) * 2002-10-31 2009-04-02 池田食研株式会社 皮膚老化防止剤
EP1437117A1 (fr) * 2002-12-19 2004-07-14 Cognis France S.A. Utilisation d'acide sinapique ou/et de ses dérivés
US20070060533A1 (en) * 2003-10-24 2007-03-15 Meiji Seika Kaisha Ltd. Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor
US20050137239A1 (en) * 2003-12-17 2005-06-23 Hines Michelle D. Thiazole derivatives
JP2007119373A (ja) * 2005-10-26 2007-05-17 Arkray Inc メイラード反応生成物分解剤およびそれを用いた飲食品
US20070098824A1 (en) * 2005-10-27 2007-05-03 Kgk Synergize Inc. Canola extracts containing high levels of phenolic acids
WO2008073684A1 (fr) * 2006-12-08 2008-06-19 Lipo Chemicals Inc. Composition pour traiter le vieillissement de la peau comprenant un acide hydroxycinnamique tel que l'acide p-coumarique

Also Published As

Publication number Publication date
WO2009007412A2 (fr) 2009-01-15
FR2918570A1 (fr) 2009-01-16
WO2009007412A3 (fr) 2009-04-02
JP2014028814A (ja) 2014-02-13
FR2975495B1 (fr) 2017-06-09
BRPI0813925A2 (pt) 2014-12-30
US20100203175A1 (en) 2010-08-12
JP2010533143A (ja) 2010-10-21
CN101765432A (zh) 2010-06-30
EP2170358A2 (fr) 2010-04-07
FR2975495A1 (fr) 2012-11-23
KR20100047253A (ko) 2010-05-07
CN103816095A (zh) 2014-05-28

Similar Documents

Publication Publication Date Title
FR2918570B1 (fr) DIGLYCATION DES AGEs.
ES1063346Y (es) Andador
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
DK2340021T3 (da) Substituerede pyrrolidin-2-carboxamider
BRPI0813144A2 (pt) Couro
FIC20240018I1 (fi) Vamoroloni
UY3776Q (es) Reloj pulsera
DK2173831T3 (da) Brøndbehandling
DK2103820T3 (da) Fikseringsenhed
BRPI0907448A2 (pt) Instrumentos.
DK2173197T3 (da) Fremgangsmåde
IT1396642B1 (it) Statore.
UY3860Q (es) Reloj
ES1066957Y (es) Pulsera
DE602007009636D1 (de) Sektionaltor
DE112009001669A5 (de) Sektionaltor
ES1066333Y (es) Reloj de pulsera.
AT506504A3 (de) Gliedermassstab
BRPI0912193A2 (pt) compostos terapêuticos.
FR2918184B1 (fr) Montre-bracelet.
FR2914850B1 (fr) Deambulateur.
DOS2008000043S (es) Muñequera
ES1067161Y (es) Reloj de pulsera
TH97348B (th) กำไล
TH97346B (th) กำไล

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17